NeuroOne Medical Technologies Corporation Revenue 2020–2025
NeuroOne Medical Technologies Corporation annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- NeuroOne Medical Technologies Corporation revenue for the quarter ending March 31, 2026 was 2.4 M, a 72.46% increase year-over-year.
- NeuroOne Medical Technologies Corporation revenue for the twelve months ending March 31, 2026 was 9.7 M.
- NeuroOne Medical Technologies Corporation annual revenue for 2025 was 9.1 M, a 163.47% increase from 2024.
- NeuroOne Medical Technologies Corporation annual revenue for 2024 was 3.5 M, a 76.86% increase from 2023.
- NeuroOne Medical Technologies Corporation annual revenue for 2023 was 2.0 M, a 1040.65% increase from 2022.
- NeuroOne Medical Technologies Corporation annual revenue for 2022 was 171169.
NeuroOne Medical Technologies Corporation (NMTC) — Frequently Asked Questions
NeuroOne Medical Technologies Corporation (NMTC) is a publicly traded US company. It has a market capitalization of $22M. In fiscal 2025 it reported revenue of $9M and net income of -$4M. Explore NMTC's stock price, financial statements, earnings history, margins and key ratios below.
What is NeuroOne Medical Technologies Corporation's market cap?
NeuroOne Medical Technologies Corporation (NMTC) has a market capitalization of $22M.
What is the NMTC stock price?
NMTC trades at $3.32 (-2.06% on the day).
How much revenue does NeuroOne Medical Technologies Corporation make?
NeuroOne Medical Technologies Corporation reported revenue of $9M in fiscal 2025.
Is NMTC profitable?
In fiscal 2025, NeuroOne Medical Technologies Corporation reported net income of -$4M.